About Beyond Air, Inc.
https://www.beyondair.netBeyond Air, Inc. operates as a commercial medical device and biopharmaceutical company. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn.
CEO
Steven Adam Lisi
Compensation Summary
(Year 2025)
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2025-07-14 | Reverse | 1:20 |
| 2017-07-11 | Reverse | 1:100 |
ETFs Holding This Stock
Summary
Showing Top 1 of 11
Ratings Snapshot
Rating : C-
Most Recent Analyst Grades
Grade Summary
Showing Top 1 of 1
Price Target
Institutional Ownership
ALYESKA INVESTMENT GROUP, L.P.
Shares:759.06K
Value:$1.43M
BLACKROCK INC.
Shares:518.99K
Value:$975.69K
LASRY MARC
Shares:81.95K
Value:$154.07K
Summary
Showing Top 3 of 19
About Beyond Air, Inc.
https://www.beyondair.netBeyond Air, Inc. operates as a commercial medical device and biopharmaceutical company. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q2-2026 | $1.82M ▲ | $7.36M ▼ | $-7.94M ▼ | -436.74% ▲ | $-1.25 ▲ | $-6.8M ▼ |
| Q1-2026 | $1.76M ▲ | $7.77M ▲ | $-7.69M ▲ | -436.99% ▲ | $-1.53 ▲ | $-6.6M ▼ |
| Q4-2025 | $1.15M ▲ | $7.14M ▼ | $-8.03M ▲ | -697.4% ▲ | $-1.79 ▲ | $-6.54M ▲ |
| Q3-2025 | $1.07M ▲ | $10.74M ▼ | $-13.03M ▲ | -1.22K% ▲ | $-2.96 ▲ | $-11.93M ▲ |
| Q2-2025 | $798K | $11.75M | $-13.36M | -1.67K% | $-5.67 | $-12.16M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q2-2026 | $10.7M ▲ | $30.96M ▲ | $17.87M ▲ | $12.73M ▲ |
| Q1-2026 | $6.46M ▼ | $28.11M ▼ | $17.71M ▲ | $9.93M ▼ |
| Q4-2025 | $6.92M ▼ | $30.06M ▼ | $15.72M ▼ | $13.58M ▼ |
| Q3-2025 | $10.95M ▼ | $34.14M ▼ | $15.76M ▼ | $17.64M ▼ |
| Q2-2025 | $28.45M | $53.01M | $23.72M | $28.13M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q2-2026 | $-7.94M ▲ | $-4.45M ▲ | $240K ▼ | $8.92M ▲ | $4.72M ▲ | $-4.7M ▲ |
| Q1-2026 | $-8.08M ▼ | $-4.53M ▲ | $576K ▼ | $4.07M ▼ | $243K ▲ | $-4.72M ▲ |
| Q4-2025 | $-8.06M ▲ | $-6.96M ▲ | $2.58M ▲ | $4.5M ▲ | $63K ▲ | $-8.46M ▼ |
| Q3-2025 | $-13.03M ▲ | $-7.73M ▲ | $-6.94M ▼ | $-9.21M ▼ | $-23.84M ▼ | $-8.27M ▲ |
| Q2-2025 | $-14.03M | $-13.35M | $16.15M | $21.62M | $24.29M | $-14.52M |
Revenue by Products
| Product | Q3-2025 | Q4-2025 | Q1-2026 | Q2-2026 |
|---|---|---|---|---|
 Business Segment | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
CEO
Steven Adam Lisi
Compensation Summary
(Year 2025)
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2025-07-14 | Reverse | 1:20 |
| 2017-07-11 | Reverse | 1:100 |
ETFs Holding This Stock
Summary
Showing Top 1 of 11
Ratings Snapshot
Rating : C-
Most Recent Analyst Grades
Grade Summary
Showing Top 1 of 1
Price Target
Institutional Ownership
ALYESKA INVESTMENT GROUP, L.P.
Shares:759.06K
Value:$1.43M
BLACKROCK INC.
Shares:518.99K
Value:$975.69K
LASRY MARC
Shares:81.95K
Value:$154.07K
Summary
Showing Top 3 of 19